BioMimetic Therapeutics, Inc. (BMTI) Posts Q3 Loss of 16c/Share
Tweet
Share
E-mailGet Alerts BMTI Hot Sheet
Price: $9.49 --0%
Financial Fact:
Depreciation and capital lease amortization: 233.35K
Today's EPS Names:
ESCA, LICT, NKSH, More
Financial Fact:
Depreciation and capital lease amortization: 233.35K
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) reported Q3 EPS of ($0.16), $0.07 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $688.7 thousand versus the consensus estimate of $390 thousand.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- Metropolitan Bank Holding Corp (MCB) Tops Q1 EPS by 12c
- Citizens Holding (CIZN) Reports Q1 EPS of $0.51
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
